Synergistic effects of the membrane actions of cecropin-melittin antimicrobial hybrid peptide BP100

Biophysical Journal

Volumn 96, Issue 5, 2009, Pages 1815-1827

  Ferre, Rafael ^a   Melo, Manuel N ^b   Correia, Ana D ^b   Feliu, Lidia ^a   Bardaji, Eduard ^a   Planas, Marta ^a   Castanho, Miguel ^b  

^a UNIVERSITY OF GIRONA   (Spain)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BP 100; LIPID; PEPTIDE; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; LYSYL LYSYL LEUCYL PHENYLALANYL LYSYL LYSYL ISOLEUCYL LEUCYL LYSYL TYROSYL LEUCINAMIDE; LYSYL-LYSYL-LEUCYL-PHENYLALANYL-LYSYL-LYSYL-ISOLEUCYL-LEUCYL-LYSYL-TYROSYL-LEUCINAMIDE; OLIGOPEPTIDE;

ANIMAL CELL; ARTICLE; BACTERIAL MEMBRANE; BINDING AFFINITY; CELL AGGREGATION; CELL MEMBRANE; CELL PERMEABILIZATION; CELL VACUOLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG TRANSPORT; ELECTRON TRANSPORT; EXPERIMENTAL MODEL; FIBROBLAST; IN VITRO STUDY; MAMMAL CELL; MEMBRANE DAMAGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARTITION COEFFICIENT; PHOSPHOLIPID BILAYER; ANIMAL; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; DRUG EFFECT; FLUORESCENCE; HAMSTER; LIGHT; LIPID BILAYER; METABOLISM; NONLINEAR SYSTEM; PHYSIOLOGY; PROTEIN BINDING; RADIATION SCATTERING; REGRESSION ANALYSIS;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CRICETINAE; FIBROBLASTS; FLUORESCENCE; LIGHT; LIPID BILAYERS; NONLINEAR DYNAMICS; OLIGOPEPTIDES; PROTEIN BINDING; REGRESSION ANALYSIS; SCATTERING, RADIATION;

EID: 65549119292     PISSN: 00063495     EISSN: 15420086     Source Type: Journal    
DOI: 10.1016/j.bpj.2008.11.053     Document Type: Article

References (79)

1. Brogden, K. A., M. Ackermann, P. B. McCray, Jr., and B. F. Tack. 2003. Antimicrobial peptides in animals and their role in host defenses. Int. J. Antimicrob. Agents. 22:465-478.
2. Bulet, P., R. Stocklin, and L. Menin. 2004. Antimicrobial peptides: from invertebrates to vertebrates. Immunol. Rev. 198:169-184.
3. Ganz, T., and R. I. Lehrer. 1998. Antimicrobial peptides of vertebrates. Curr. Opin. Immunol. 10:41-44.
4. Garcia-Olmedo, F., A. Molina, J. M. Alamillo, and P. Rodriguez- Palenzuela. 1998. Plant defense peptides. Biopolymers. 47:479-491.
5. Otvos, L., Jr. 2000. Antibacterial peptides isolated from insects. J. Pept. Sci. 6:497-511.
6. Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature. 415:389-395.
7. Broekaert, W. F., B. P. A. Cammue, M. F. C. DeBolle, K. Thevissen, G. W. DeSamblanx, et al. 1997. Antimicrobial peptides from plants. Crit. Rev. Plant Sci. 16:297-323.
8. Hancock, R. E., and A. Patrzykat. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr. Drug Targets Infect. Disord. 2:79-83.
9. Hancock, R. E., and H. G. Sahl. 2006. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat. Biotechnol. 24:1551-1557.
10. Boman, H. G. 2003. Antibacterial peptides: basic facts and emerging concepts. J. Intern. Med. 254:197-215.
11. Hancock, R. E. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1:156-164.
12. Jenssen, H., P. Hamill, and R. E. Hancock. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
13. Montesinos, E. 2007. Antimicrobial peptides and plant disease control. FEMS Microbiol. Lett. 270:1-11.
14. Zhang, L., and T. J. Falla. 2006. Antimicrobial peptides: therapeutic potential. Expert Opin. Pharmacother. 7:653-663.
15. Brogden, K. A. 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3:238-250.
16. Yeaman, M. R., and N. Y. Yount. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev. 55:27-55.
17. Perron, G. G., M. Zasloff, and G. Bell. 2006. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci. 273:251-256.
18. Shai, Y. 2002. Mode of action of membrane active antimicrobial peptides. Biopolymers. 66:236-248.
19. Tossi, A., L. Sandri, and A. Giangaspero. 2000. Amphipathic, α-helical antimicrobial peptides. Biopolymers. 55:4-30.
20. Bechinger, B. 2004. Structure and function of membrane-lytic peptides. Crit. Rev. Plant Sci. 23:271-292.
21. Yang, L., T. A. Harroun, T. M. Weiss, L. Ding, and H. W. Huang. 2001. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J. 81:1475-1485.
22. Shai, Y. 1999. Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by α-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim. Biophys. Acta. 1462:55-70.
23. Kobayashi, S., A. Chikushi, S. Tougu, Y. Imura, M. Nishida, et al. 2004. Membrane translocation mechanism of the antimicrobial peptide buforin 2. Biochemistry. 43:15610-15616.
24. Hultmark, D., A. Engstrom, H. Bennich, R. Kapur, and H. G. Boman. 1982. Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae. Eur. J. Biochem. 127:207-217.
25. Hultmark, D., H. Steiner, T. Rasmuson, and H. G. Boman. 1980. Insect immunity. Purification and properties of three inducible bactericidal proteins from hemolymph of immunized pupae of Hyalophora cecropia. Eur. J. Biochem. 106:7-16.
26. Sato, H., and J. B. Feix. 2006. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic α-helical antimicrobial peptides. Biochim. Biophys. Acta. 1758:1245-1256.
27. Andreu, D., R. B. Merrifield, H. Steiner, and H. G. Boman. 1983. Solidphase synthesis of cecropin A and related peptides. Proc. Natl. Acad. Sci. USA. 80:6475-6479.
28. Steiner, H., D. Hultmark, A. Engstrom, H. Bennich, and H. G. Boman. 1981. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature. 292:246-248.
29. Alberola, J., A. Rodriguez, O. Francino, X. Roura, L. Rivas, et al. 2004. Safety and efficacy of antimicrobial peptides against naturally acquired Leishmaniasis. Antimicrob. Agents Chemother. 48:641-643.
30. Andreu, D., J. Ubach, A. Boman, B. Wahlin, D. Wade, et al. 1992. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 296:190-194.
31. Boman, H. G., D. Wade, I. A. Boman, B. Wahlin, and R. B. Merrifield. 1989. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 259:103-106.
32. Cavallarin, L., D. Andreu, and B. San Segundo. 1998. Cecropin A-derived peptides are potent inhibitors of fungal plant pathogens. Mol. Plant Microbe Interact. 11:218-227.
33. Chicharro, C., C. Granata, R. Lozano, D. Andreu, and L. Rivas. 2001. N-terminal fatty acid substitution increases the leishmanicidal activity of CA(1-7)M(2-9), a cecropin-melittin hybrid peptide. Antimicrob. Agents Chemother. 45:2441-2449.
34. 2 on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. Diagn. Microbiol. Infect. Dis. 49:197-200.
35. Lee, D. G., Y. Park, I. Jin, K. S. Hahm, H. H. Lee, et al. 2004. Structure-antiviral activity relationships of cecropin A-magainin 2 hybrid peptide and its analogues. J. Pept. Sci. 10:298-303.
36. Wade, D., D. Andreu, S. A. Mitchell, A. M. Silveira, A. Boman, et al. 1992. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin. Int. J. Pept. Protein Res. 40:429-436.
37. Ali, G. S., and A. S. Reddy. 2000. Inhibition of fungal and bacterial plant pathogens by synthetic peptides: in vitro growth inhibition, interaction between peptides and inhibition of disease progression. Mol. Plant Microbe Interact. 13:847-859.
38. Badosa, E., R. Ferre, M. Planas, L. Feliu, E. Besalu, et al. 2007. A library of linear undecapeptides with bactericidal activity against phytopathogenic bacteria. Peptides. 28:2276-2285.
39. Bardají, E., E. Montesinos, E. Badosa, L. Feliu, M. Planas, et al. 2006. Antimicrobial linear peptides. P200601098; priority date: April 28th, 2006; Oficina Española de Patentes y Marcas, Spain.
40. Ferre, R., E. Badosa, L. Feliu, M. Planas, E. Montesinos, et al. 2006. Inhibition of plant-pathogenic bacteria by short synthetic cecropin A-melittin hybrid peptides. Appl. Environ. Microbiol. 72:3302-3308.
41. Christensen, B., J. Fink, R. B. Merrifield, and D. Mauzerall. 1988. Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. USA. 85:5072-5076.
42. Ladokhin, A. S., M. E. Selsted, and S. H. White. 1997. Sizing membrane pores in lipid vesicles by leakage of co-encapsulated markers: pore formation by melittin. Biophys. J. 72:1762-1766.
43. Ladokhin, A. S., and S. H. White. 2001. "Detergent-like" permeabilization of anionic lipid vesicles by melittin. Biochim. Biophys. Acta. 1514:253-260.
44. Silvestro, L., K. Gupta, J. N. Weiser, and P. H. Axelsen. 1997. The concentration-dependent membrane activity of cecropin A. Biochemistry. 36:11452-11460.
45. Steiner, H., D. Andreu, and R. B. Merrifield. 1988. Binding and action of cecropin and cecropin analogues: antibacterial peptides from insects. Biochim. Biophys. Acta. 939:260-266.
46. Mayer, L. D., M. J. Hope, and P. R. Cullis. 1986. Vesicles of variable sizes produced by a rapid extrusion procedure. Biochim. Biophys. Acta. 858:161-168.
47. Santos, N. C., and M. A. Castanho. 2002. Fluorescence spectroscopy methodologies on the study of proteins and peptides. On the 150th anniversary of protein fluorescence. Trends Appl. Spectrosc. 4:113-125.
48. 1 and alcohol-dehydrogenase fluorescence quenching by acrylamide - a laboratory experiment for undergraduate students. J. Chem. Educ. 70:425-428.
49. Santos, N. C., M. Prieto, and M. A. Castanho. 2003. Quantifying molecular partition into model systems of biomembranes: an emphasis on optical spectroscopic methods. Biochim. Biophys. Acta. 1612:123-135.
50. Nagle, J. F., and M. C. Wiener. 1988. Structure of fully hydrated bilayer dispersions. Biochim. Biophys. Acta. 942:1-10.
51. Ladokhin, A. S., S. Jayasinghe, and S. H. White. 2000. How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal. Biochem. 285:235-245.
52. Wenk, M. R., and J. Seelig. 1998. Magainin 2 amide interaction with lipid membranes: calorimetric detection of peptide binding and pore formation. Biochemistry. 37:3909-3916.
53. Melo, M. N., and M. A. Castanho. 2007. Omiganan interaction with bacterial membranes and cell wall models. Assigning a biological role to saturation. Biochim. Biophys. Acta. 1768:1277-1290.
54. Chalpin, D. B., and A. M. Kleinfeld. 1983. Interaction of fluorescence quenchers with the n-(9-anthroyloxy) fatty acid membrane probes. Biochim. Biophys. Acta. 731:465-474.
55. Fernandes, M. X., J. Garcia de la Torre, and M. A. Castanho. 2002. Joint determination by Brownian dynamics and fluorescence quenching of the in-depth location profile of biomolecules in membranes. Anal. Biochem. 307:1-12.
56. Chattopadhyay, A., and E. London. 1988. Spectroscopic and ionization properties of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-labeled lipids in model membranes. Biochim. Biophys. Acta. 938:24-34.
57. Pokorny, A., and P. F. Almeida. 2004. Kinetics of dye efflux and lipid flip-flop induced by δ-lysin in phosphatidylcholine vesicles and the mechanism of graded release by amphipathic, α-helical peptides. Biochemistry. 43:8846-8857.
58. Lakowicz, J. R. 1999. Quenching of fluorescence. Principles of Fluorescence Spectroscopy, 2nd Ed. Kluwer Academic/Plenum, New York; London.
59. Gregory, S. M., A. Cavenaugh, V. Journigan, A. Pokorny, and P. F. Almeida. 2008. A quantitative model for the all-or-none permeabilization of phospholipid vesicles by the antimicrobial peptide cecropin A. Biophys. J. 94:1667-1680.
60. Rueff, J., C. Chiapella, J. K. Chipman, F. Darroudi, I. D. Silva, et al. 1996. Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays. Mutat. Res. 353:151-176.
61. Zucco, F., I. De Angelis, and A. Stammati. 1998. Cellular models for in vitro toxicity testing. In Animal Cell Culture Techniques. M. Clynes, editor. Springer, Berlin; London.
62. Mickuviene, I., V. Kirveliene, and B. Juodka. 2004. Experimental survey of non-clonogenic viability assays for adherent cells in vitro. Toxicol. In Vitro. 18:639-648.
63. Mitchell, J. B. 1988. Potential applicability of nonclonogenic measurements to clinical oncology. Radiat. Res. 114:401-414.
64. Brink, C. B., A. Pretorius, B. P. van Niekerk, D. W. Oliver, and D. P. Venter. 2008. Studies on cellular resilience and adaptation following acute and repetitive exposure to ozone in cultured human epithelial (HeLa) cells. Redox Rep. 13:87-100.
65. Cudic, M., C. V. Lockatell, D. E. Johnson, and L. Otvos, Jr. 2003. In vitro and in vivo activity of an antibacterial peptide analog against uropathogens. Peptides. 24:807-820.
66. Scholze, M., W. Boedeker, M. Faust, T. Backhaus, R. Altenburger, et al. 2001. A general best-fit method for concentration-response curves and the estimation of low-effect concentrations. Environ. Toxicol. Chem. 20:448-457.
67. Zhao, H., R. Sood, A. Jutila, S. Bose, G. Fimland, et al. 2006. Interaction of the antimicrobial peptide pheromone Plantaricin A with model membranes: implications for a novel mechanism of action. Biochim. Biophys. Acta. 1758:1461-1474.
68. Huang, H. W. 2000. Action of antimicrobial peptides: two-state model. Biochemistry. 39:8347-8352.
69. Huang, H. W. 2006. Molecular mechanism of antimicrobial peptides: the origin of cooperativity. Biochim. Biophys. Acta. 1758:1292-1302.
70. Segrest, J. P., H. De Loof, J. G. Dohlman, C. G. Brouillette, and G. M. Anantharamaiah. 1990. Amphipathic helix motif: classes and properties. Proteins. 8:103-117.
71. Kandasamy, S. K., and R. G. Larson. 2006. Molecular dynamics simulations of model trans-membrane peptides in lipid bilayers: a systematic investigation of hydrophobic mismatch. Biophys. J. 90:2326-2343.
72. Abrunhosa, F., S. Faria, P. Gomes, I. Tomaz, J. C. Pessoa, et al. 2005. Interaction and lipid-induced conformation of two cecropin-melittin hybrid peptides depend on peptide and membrane composition. J. Phys. Chem. B. 109:17311-17319.
73. Juvvadi, P., S. Vunnam, E. L. Merrifield, H. G. Boman, and R. B. Merrifield. 1996. Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids. J. Pept. Sci. 2:223-232.
74. Rathinakumar, R., and W. C. Wimley. 2008. Biomolecular engineering by combinatorial design and high-throughput screening: small, soluble peptides that permeabilize membranes. J. Am. Chem. Soc. 130:9849-9858.
75. Henriques, S. T., M. N. Melo, and M. A. Castanho. 2007. How to address CPP and AMP translocation? Methods to detect and quantify peptide internalization in vitro and in vivo. (Review). Mol. Membr. Biol. 24:173-184.
76. Matsuzaki, K., S. Yoneyama, O. Murase, and K. Miyajima. 1996. Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry. 35:8450-8456.
77. Persson, D., P. E. Thoren, and B. Norden. 2001. Penetratin-induced aggregation and subsequent dissociation of negatively charged phospholipid vesicles. FEBS Lett. 505:307-312.
78. Otvos, L., Jr., K. Bokonyi, I. Varga, B. I. Otvos, R. Hoffmann, et al. 2000. Insect peptides with improved protease-resistance protect mice against bacterial infection. Protein Sci. 9:742-749.
79. Friedrich, C. L., D. Moyles, T. J. Beveridge, and R. E. Hancock. 2000. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob. Agents Chemother. 44:2086-2092.